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In this study, we sought to investigate the expression of the transcription factor E2F1 in chicken pulmonary arterial
smooth muscle cells upon hypoxia exposure, as well as the role that E2F1 played in the regulation of cell
proliferation. Isolated chicken pulmonary arterial smooth muscle cells were subjected to hypoxia or normoxia for
indicated time points. Cell viability, DNA synthesis, cell cycle profile, and expression of E2F1 were analyzed. The
results showed that hypoxia promoted cell proliferation and DNA synthesis which was accompanied by an
increased S phase entry and upregulation of E2F1 at mRNA and protein levels. Using siRNA technology, we
demonstrated that gene inactivation of endogenous E2F1 abolished hypoxia-induced cell proliferation, DNA
synthesis, and S phase entry compared with negative siRNA transfected cells. These results suggest that
hypoxia-induced proliferation is mediated by inducing E2F1 in chicken pulmonary arterial smooth muscle cells.
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Pulmonary arterial hypertension is a disease of the small
pulmonary arteries characterized by vascular dysfunction
and structural remodeling [1,2]. Vascular remodeling
leads to an increase of pulmonary vascular resistance,
sustained arterial hypertension and ultimately results in
right ventricular hypertrophy and death [3-5]. Both
physical (for example, mechanical stretch, shear stress)
and chemical (hypoxia, vasoactive substances, growth
factors) stimuli have been reported to be risk factors as-
sociated with vascular remodeling in various animal
models or humans. Among them, hypoxia plays an
important role by modulating the production of anti-
mitogenic factors, mitogenic factor, the release of inflam-
matory cytokines, and the induction of hypoxia-related
transcription factors [4,6]. During the vascular remodel-
ing process in response to stimuli, the predominant cell
types (fibroblasts, smooth muscle cells, and endothelial* Correspondence: cauvet@163.com; bio2046@hotmail.com
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reproduction in any medium, provided the orcells) within each of the three layers of the blood vessel
wall are affected. More and more recent evidence shows
that the abnormal proliferation of smooth muscle cells
might be the primary alteration that complicates and
contributes to hypoxia-induced vascular remodeling [7].
Pulmonary arterial hypertension, also known as ascites
syndrome in broilers, is one of the metabolic diseases
characterized by an enlarged flaccid heart, variable liver
changes, and accumulation of fluid in the abdominal
cavity [8]. It is a widely used experimental model due to
its apparent characteristics of pulmonary hypertension
and vascular remodeling, as well as its highly reprodu-
cible in experimental condition [9,10]. Even though the
etiology of ascites syndrome appears to be multi-
factorial, it is generally believed that hypoxia promoted
cellular proliferation due to the demand for oxygen ex-
ceeds its cardiopulmonary capacity is the predominant
stimulus associated with the development of vascular
remodeling [6,8,9,11]. We and others are interested in
uncovering the underlying mechanisms and providing
potential therapeutic strategies to alleviate the detri-
mental effect of ascites on broilers in the past few years
[9,10,12,13]. In our recent study, we found that exposure
to hypoxia induces pulmonary hypertension characterizedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in broilers which can be reduced by sodium hydrosulfide
administration in vivo [14]. However, the underlying
mechanisms are unknown.
E2F1 is a transcription factor with multiple cellular
functions in regulating cellular response such as cell
proliferation, differentiation, development, and apoptosis
[15,16]. De-regulation of E2F1 has been reported to be
associated with cell proliferation in many cell lines. In
normal cells, the activity of E2F1 is tightly controlled to
keep cellular homeostasis though multiple levels of regu-
lation. In response to stress or mitogenic stimulus, E2F1
can promote cell cycle progression by activating down-
stream genes implicated in G1/S transition [17]. Also it
has been reported that E2F1 can be induced in response
to hypoxia in human pulmonary arterial smooth muscle
cells [18]. These data suggest that E2F1 might be a can-
didate gene that regulating the proliferation of smooth
muscle cells and contributes to hypoxia-induced vascu-
lar remodeling in broilers. Therefore, the aim of this
study was to evaluate whether hypoxia-induced prolifer-
ation of chicken pulmonary arterial smooth muscle cells
was mediated by E2F1 activation.
Materials and methods
M199 and DMEM media, fetal bovine serum (FBS), anti-
biotics (penicillin and streptomycin), and other cell culture
supplements were obtained from Invitrogen (Carlsbad,
CA). Protease and phosphatase inhibitor cocktails were
obtained from Roche Molecular Systems, Inc. (Alameda,
CA). Molecular weight markers and reagents for protein
determination were from Bio-Rad (Cambridge, MA). Anti-
bodies against E2F1, CCNE1, β-actin, and horseradish
peroxidase-conjugated goat anti-rabbit immunoglobulin G
were from Santa Cruz Biotechnology (Santa Cruz, CA).
Polyvinylidene difluoride (PVDF) membrane was obtained
from Amersham Pharmacia Biotech. Other reagents used
in this study were obtained from Sigma (St. Louis, MO.)
otherwise as stated.
Isolation and culture of chicken pulmonary arterial
smooth muscle cells (PASMCs)
All animal care and procedures were in accordance with
institutional and international guidelines. Twenty day-
old chicken embryo pulmonary arterial smooth muscle
cells (PASMCs) were isolated by enzymatic digestion as
previously described [19,20]. In brief, proximal pulmon-
ary arteries were isolated under aseptic condition and
were cut into small pieces after removal of fat, adventi-
tia, and connective tissue surrounding the arteries. After
incubation for 90 min in DMEM medium supplemented
with elastase type III (0.125 mg/mL), collagenase type I
(0.5 mg/mL), and antibiotics (100 U/mL penicillin and
100 μg/mL streptomycin), the tissues suspension wascentrifuged for 15 min at 1,500 g and the pellet was
resuspended in M199 media supplemented with 10%
FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, 8
mmol/L HEPES, and 2 mmol/L glutamine at 39°C in a
humidified atmosphere of 5% CO2/95% air environment.
PASMCs were passaged with 0.05% trypsin and cells of
passages 3–8 were used in all the experiments. 95% per-
cent cells exhibited specific immunostaining by anti-α-
smooth muscle-actin antibody, a generally accepted
marker of smooth muscle cells [21] as expected.
Cell proliferation assay
Proliferation of PASMCs was measured by 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide
(MTT) assay as previously described [18]. Briefly, cells
were seeded in 96-well plates at a density of 2,000 cells
each well under normoxic or hypoxic conditions for in-
dicated time points. At the end of treatment, 10 μL
MTT (5 mg/mL)/well was added to each well of the
plates, and incubated for another 4 h at 37°C. The super-
natant was then carefully removed, and 75 μL/well di-
methyl sulfoxide (DMSO) was added to dissolve the
formazan crystals. The absorbance of the solubilized
product at 570 nm was measured with microplate spec-
trophotometer (PowerWave XS, BioTek Inc, Vermont).
[3H] Thymidine incorporation assay
Thymidine incorporation assay was performed according
to the method described previously [20,22]. Briefly,
PASMCs were seeded in complete growth medium at a
density of 20,000 cells/well in 24-well plates. After 24 h,
cells were growth-arrested by serum starvation with low
serum medium (0.1% FBS) for 48 h. Arrested cells were
labeled with [3H]-thymidine at 25Ci/mL and then were
subjected to normoxia or hypoxia. Cells were harvested
at indicated time points in 1% sodium dodecyl sulfate
(SDS)/0.01 mol/L NaOH. [3H] thymidine incorporation
was determined in a Becton scintillation counter (model
LS6500, Franklin Lakes, NJ).
Cell Cycle Analysis
Cell cycle was determined by flow cytometry as de-
scribed previously [23]. Treated cells were harvested and
washed two times with cold PBS, and then were fixed
with 1 mL of 70% ethanol overnight at 4°C. Fixed cells
were centrifuged for 3 min at 1,200 g and then were
washed with cold PBS and resuspended in PBS with 50
mg/mL prepodium iodide (PI) and 1 mg/mL RNase. The
stained cells were analyzed for DNA content by
fluorescence-activated cell sorting (FACs) in a FACs
Calibur (Becton Dickinson Instrument, San Jose, CA).
Cell cycle fractions were quantified using the CellQuest
software (Becton Dickinson).
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Total RNA was extracted from the PASMCs using an
RNeasy Mini kit (Qiagen, Valencia, CA) according to
the manufacturer's instructions and estimated using
optical density measurements. Total RNA (2 μg) was
used for first-strand cDNA synthesis using random
hexamer primers and Superscript Reverse Transcript-
ase (Invitrogen, Carlsbad, CA). Quantitative real-time
PCR was used to quantify the expression level of E2F1.
PCR reactions were set up with SYBR Green PCR
Supermix (Bio-Rad, Hercules, CA) using 1 μL of cDNA
in each 20-μL reaction mixture). The relative values of
gene expression were calculated using the ΔΔCT method
with β-actin as the internal control. The values were nor-
malized to the average value of the control samples.
siRNA transfection
Transfection reagent Lipofectamine-2000 was obtained
from Invitrogen (Carlsbad, CA). The procedure for
siRNA transfection was performed as previously de-
scribed [18]. 48 h after siRNA transfection, cells were
seeded in 6-well plates and subjected to normoxia or
hypoxia for another 24 h; cells were then collected for
Western blot analysis or DNA synthesis assay.
Western blot analysis
The total lysate was obtained from PASMCs using ice-
cold lysis buffer containing 20 mmol/L Tris–HCl (pH
7.4), 2.5 mmol/L EDTA, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% SDS, 200 mmol/L NaF, 100 mmol/L
Na3VO4 and 1 mmol/L protease inhibitor cocktail
from Roche (Alameda, CA). Cell lysates were cen
trifuged for 15 min at 16,000 g to remove cellular deb-
ris. Equal amounts of protein were separated on SDS-
page gels and transfer to PVDF membranes (Millpore,Figure 1 Effect of hypoxia on the proliferation of chicken pulmonary
normoxia (21% oxygen) or under different concentrations of hypoxia (1%, 2
were analyzed by using MTT assay and [3H]-thymidine incorporation assay
each performed in triplicate. (C) PASMCs were exposed to normoxia (21%
was determined and expressed as mean ± SEM of five separate experimen
time point were set as 100%, *P<0.05 compared with normoxic control.Bedford, MA). The membranes were blocked in 5%
non-fat milk at room temperature for 1 h, and then
were incubated with primary antibodies against β-
actin, E2F1, CCNE1, overnight at 4°C and then washed
three times with PBST. The membranes were incubated
with horseradish peroxidase-conjugated secondary anti-
body for 1 h. The signal detection was performed by using
the enhanced chemiluminescence substrates (ECL Plus re-
agent; Amersham Pharmacia Biotech, San Diego, CA).
Statistical analysis
Comparisons between groups were performed using
two-way ANOVA followed by the Duncans test. Differ-
ences were considered statistically significant at the level
of P <0.05 and values are represented as means ± SEM.
The statistical analysis was performed with the software
of SPSS 11.0 for Windows.
Results
Effect of hypoxia on the proliferation and DNA synthesis
in chicken PASMCs
Arrested PASMCs were subjected to normoxic (21% oxy-
gen) or different oxygen as indicated (1%, 2%, 3%, or 5%)
for 24 h and cell proliferation was analyzed. A significant
increase in cell viability was observed in PASMCs exposed
to 1%, 2%, and 3% oxygen as evidenced by MTT assay
(Figure 1A) and [3H]thymidine incorporation assay
(Figure 1B). 5% oxygen induced a modest proliferation
in PASMCs, and the difference was not significant. More-
over, the pro-proliferative effect of hypoxia (2% oxygen)
on the proliferation of PASMCs was time-dependent and
sustained to 72 h compared with normoxic control cells at
each time point (Figure 1C). Because 2% oxygen exposure
has the greatest effect on cell proliferation, we choose it
for further study.arterial smooth muscle cells (PASMCs). PASMCs were exposed to
%, 3%, or 5% oxygen) for 24 h, cell viability (A) and DNA synthesis (B)
respectively. Each value is mean ± SEM of five separate experiments,
oxygen) or hypoxia (2% oxygen) for indicated time points, cell viability
ts, each performed in triplicate. Values for the normoxic cells at each
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activation of E2F1 in chicken PASMCs
Because the proliferation of PASMCs was markedly
promoted following hypoxia exposure (2% oxygen), we
next determined whether the cell cycle was also
changed in response to hypoxia exposure. Flow cytom-
etry analysis showed that hypoxia promoted cell cycle
progression as shown by an increased cell population
in S phase compared with control cells cultured under
normoxic condition (Figure 2A). To determine whether
the transcription factor E2F1 was involved in the S
phase entry observed, protein was extracted from cells
in the presence or absence of hypoxia for 24 h. Western
blot results showed that hypoxia significantly up-
regulated E2F1 protein level as well as downstream tar-
get CCNE1 (Figure 2B and C). This result indicates that
hypoxia-induced G1/S transition is associated with in-
duction of E2F1 in our system.
Silencing of E2F1 reduced hypoxia-induced cell
proliferation and DNA synthesis
To test whether the E2F1 signaling pathway is res-
ponsible for hypoxia-induced cell proliferation and
DNA synthesis, Chicken PASMCs transfected with
negative siRNA or E2F1 specific siRNA were subjected
to normoxia (21% oxygen) or hypoxia (2% oxygen). Real
time-PCR (RT-PCR) result showed that endogenous
E2F1 mRNA level was greatly reduced by E2F1 siRNA
compared with control cells (siNC) (Figure 3A). More-
over, hypoxia-induced E2F1 up-regulation was mark-
edly reduced by E2F1 siRNA, but not by negative
control siRNA (Figure 3A). This result was validated by
Western blot analysis (Figure 3B and C). MTT and DNA
synthesis assays demonstrated that hypoxia-induced cellFigure 2 Hypoxia induces S phase entry and E2F1 activation in chicke
oxygen) or hypoxic (2% oxygen) conditions for 24 h. (A) Cell cycle profile w
methods. (B) Cells were treated as in (A), and the protein level of E2F1, CC
E2F1 and CCNE1 were determined from the immunoblots by densitometri
normoxic control.proliferation and DNA synthesis were significantly bloc-
ked in siE2F1 transfected cells, but not in the control cells
(Figure 3D and E), indicating that E2F1 is responsible
for hypoxia-induced cell proliferation effect in chicken
PASMCs.
Discussion
The key finding of this study is hypoxia-induced cell
proliferation is associated with up-regulation of the tran-
scription factor E2F1 in chicken pulmonary arterial
smooth muscle cells (PASMCs). Gene inactivation of
E2F1 using siRNA demonstrated that up-regulation of
E2F1 is responsible for the proliferative effect observed
in our system.
The control of cellular proliferation, including the
entry from quiescence (G0) into the cell cycle (G1) and
passage into the DNA replication (S) phase, is tightly
regulated by multiple regulators to maintain cellular
homeostasis. The E2F1 transcription factor has been well
known for its ability to regulate cell cycle progression by
controlling the expression of genes essential for the
entry into the S phase of the cell cycle, such as CCNE1
(Cyclin E1) and CCNA2 (Cyclin A2) [24-26]. The retino-
blastoma (Rb) protein is a negative regulator of E2F1
and is controlled by the activity of upstream cyclin-
dependent kinases (CDKs) that are activated during the
transition from G0 to G1. Cyclin-dependent kinase in-
hibitors, or CKIs, can block activation of CDKs and thus
regulates the activity and related function of E2F1. Due
to the existence of negative and positive regulators, the
cellular proliferation activity of E2F1 is well controlled.
Disruption of components of this pathway leads to
deregulated proliferation [15]. In this study, we, for the
first time, demonstrated that hypoxia exposure up-n PASMCs. Chicken PASMCs were cultured under normoxic (21%
as determined using the method as described in materials and
NE1, and β-actin were analyzed. (C) The relative expression levels of
c analysis. Values are mean ± SEM (n=5). *P<0.05 compared with
Figure 3 E2F1 inactivation abolishes hypoxia-induced proliferation and DNA synthesis in PASMCs. Cells transfected with negative control
siRNA (siNC) or E2F1 siRNA (siE2F1) were cultured under hypoxic (2% oxygen) or normoxic conditions for 24 h. (A) The mRNA level of E2F1, (B)
the protein levels of E2F1, CCNE1, and β-actin, (C) the relative protein levels of E2F1 and CCNE1 were determined from the immunoblots by
densitometric analysis. (D) Cell viability and (E) DNA synthesis were determined using the methods as described in materials and methods.
Values are mean ± SEM (n=5). *P<0.05 compared with hypoxic cell transfected with negative siRNA.
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that associated with G1/S transition [27] in chicken
PASMCs. As expected, activation of E2F1 was accom-
panied by an increase of S phase cell population and
DNA synthesis. Interestingly, hypoxia-induced pheno-
type was abolished by E2F1 siRNA transfection, sup-
porting a critical role of E2F1 in this stress response.
This result was in agreement with a recent study show-
ing that repressing E2F1 reversed hypoxia-induced pro-
liferation in mice PASMCs [18]. More study is needed
to elucidate the precise mechanism that responsible for
the proliferative effect observed upon hypoxia exposure.
It should be noted that besides E2F1, E2F2 and E2F3
can also activate genes associated with G1/S transition
and involve in cell cycle progression [15,16]. Further
study is needed to clarify whether E2F2 or E2F3 is acti-
vated in response to hypoxia exposure and contribute to
this effect.
Hypoxia-inducible transcription factors (HIFs), including
HIF-1α, HIF-2α, and HIF-3α, were reported to be expressed
in hypoxic smooth muscle cells and regulate gene expres-
sion via the hypoxia-responsive-element [28]. Studies of
mice partially deficient for HIF-1α showed delayed develop-
ment of pulmonary vascular remodeling, pulmonary hyper-
tension, and right ventricular hypertrophy [29], suggestingan important role of HIF-1α in the development of vascu-
lar remodeling. We did not determine the expression level
of HIF-1α due to the unavailability of antibody that cross-
react with chicken PASMCs. Considering the diverse
downstream targets of HIF-1α and E2F1, It will be of great
significance to investigate the potential interaction be-
tween these two signaling pathways.
In conclusion, we demonstrated that hypoxia exposure
promotes proliferation in chicken pulmonary arterial
smooth muscle cells by activation of transcription factor
E2F1 which can be blocked by siRNA-mediated gene si-
lence. This observation revealed a novel mechanism
underlying the regulation of proliferation by E2F1 in hyp-
oxic pulmonary hypertension and vascular remodeling.
Blocking E2F1 activity through genetic modification or
small molecule might be a potential strategy for the inhib-
ition of hypoxia-induced pulmonary vascular remodeling.
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